+987.9%
MRNA vs FDX
+65.6%
+922.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FDX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +3.6% | +9.5% | +12.4% |
| 7D | +20.6% | +8.1% | +12.5% | +19.1% |
| 30D | +27.1% | +13.9% | +13.2% | +24.5% |
| 3M | +353.4% | +5.5% | +347.8% | +349.6% |
| 6M | +446.3% | +15.1% | +431.1% | +412.3% |
| YTD | +776.2% | +43.2% | +733.0% | +558.1% |
| 1Y | +987.9% | +65.0% | +922.9% | +608.9% |
| All | +987.9% | +65.6% | +922.3% | +608.9% |
Cumulative growth
Daily Returns
Daily percentage return beside FDX.
Daily Out/Under-Performance
Portfolio return minus FDX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FDX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FDX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling